DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
KEY PRODUCTS
Reset all filters
01 1Dr. Reddy's Laboratories
Reset all filters
01 1TUCATINIB COPOVIDONE ASD
Reset all filters
01 1India
Reset all filters
01 1Active
Reset all filters
01 1Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 42336
Submission : 2025-08-19
Status : Active
Type : II
20
Dr Reddys Laboratories Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
One of their notable products is TUCATINIB COPOVIDONE ASD, with a corresponding US DMF Number 42336.
Remarkably, this DMF maintains an Active status since its submission on August 19, 2025, highlighting commitment to regulatory compliance.